US EditionEU Regulator Green Lights an Injectable HIV Drug That Could Help Stop ...
7 Articles
7 Articles
The European Medicines Agency (EMA) on Friday recommended the approval of the HIV prevention injection Yeztugo from the American company Gilead Sciences, whose vice president is Czech virologist and biochemist Tomáš Cihlář. According to the EMA, the drug is highly effective.
This is a new hope in the fight against HIV. This Friday, the European Medicines Agency gave its green light to a new preventive treatment against the AIDS virus. An innovative medicine that is part of what we call the PREPs.
“This medicine could change the traceability of the HIV epidemic”, considers Winnie Yynyima, UNAIDS Executive Director, UNAIDS Agency for HIV/AIDS. Studies conducted last year have shown that lencapavir is nearly 100% effective in preventing infection in both women and men. The medicine is developed by the American biotechnology and pharmaceutical company Gilead Sciences. The European Medicines Agency (EMA) recommended authorisation of lencapavi…
EU regulator green lights injectable HIV drug that could help stop transmission
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement on Friday, the EU drug regulator said its...
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
